Walvax Biotechnology Dividends and Buybacks
Dividend criteria checks 0/6
Walvax Biotechnology is a dividend paying company with a current yield of 0.083%.
Key information
0.08%
Dividend yield
0.4%
Buyback Yield
Total Shareholder Yield | 0.5% |
Future Dividend Yield | 0.8% |
Dividend Growth | 5.0% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.010 |
Payout ratio | 13% |
Recent dividend and buyback updates
Recent updates
Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Share Price Not Quite Adding Up
Jan 18We Think Walvax Biotechnology (SZSE:300142) Can Stay On Top Of Its Debt
Nov 25Some Confidence Is Lacking In Walvax Biotechnology Co., Ltd.'s (SZSE:300142) P/S
Sep 24Is Walvax Biotechnology (SZSE:300142) A Risky Investment?
Jun 19Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Prospects Need A Boost To Lift Shares
May 23There May Be Reason For Hope In Walvax Biotechnology's (SZSE:300142) Disappointing Earnings
Apr 07Walvax Biotechnology Co., Ltd. (SZSE:300142) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 02Is Walvax Biotechnology (SZSE:300142) A Risky Investment?
Mar 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300142 is not paying a notable dividend for the CN market, therefore no need to check if payments are stable.
Growing Dividend: 300142 is not paying a notable dividend for the CN market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
Walvax Biotechnology Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (300142) | 0.08% |
Market Bottom 25% (CN) | 0.5% |
Market Top 25% (CN) | 2.2% |
Industry Average (Biotechs) | 1.3% |
Analyst forecast (300142) (up to 3 years) | 0.8% |
Notable Dividend: 300142's dividend (0.083%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300142's dividend (0.083%) is low compared to the top 25% of dividend payers in the CN market (2.18%).
Earnings Payout to Shareholders
Earnings Coverage: 300142 is not paying a notable dividend for the CN market.
Cash Payout to Shareholders
Cash Flow Coverage: 300142 is not paying a notable dividend for the CN market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/07 09:50 |
End of Day Share Price | 2025/02/07 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Walvax Biotechnology Co., Ltd. is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Shuchang Liu | Changjiang Securities Co. LTD. |
Tong Zhang | China Merchants Securities Co. Ltd. |
Ling Bo Tu | China Minzu Securities |